May 02, 2025

Psychotherapy, Family Tied to Better Outcomes

In a large meta-analysis, researchers identified the most effective components of collaborative care for treating depression in primary care.

Conexiant

May 02, 2025

CRP in CSF Accurately Detects Meningitis, Study 

CRP in cerebrospinal fluid showed high accuracy in diagnosing bacterial meningitis, helping doctors detect cases even when standard CSF markers appear normal.

Conexiant

May 02, 2025

ADA calls for increased funding for Indian Health Service

A coalition dedicated to improving health care for American Indians and Alaska Natives is urging Congress to support funding for IHS.

ADA News

May 01, 2025

Conservative Caries Management to Preserve Tooth Structure

Sealants and specialty burs enable minimally invasive treatment for incipient and developed lesions

Inside Dentistry

May 01, 2025

Myopia: Spectacle Lens Use

While these spectacle lenses are not yet approved by the US Food and Drug Administration, it’s likely a nod from the organization is not too far off. As a result, discussing the factors that influence treatment success makes sense.

Optometric Management

May 01, 2025

Viewpoint from the Editor

It's not just about teaching; it's about believing in someone else's potential and helping them to see it for themself.

Ophthalmology Management

May 01, 2025

Health Care Faces New Immigration Reality

Health care facilities face new challenges as sensitive locations policy protecting them from immigration enforcement was rescinded in January 2025, requiring new protocols for patient protection.

Conexiant

May 01, 2025

Contact Lenses: Comanaging Corneal Crosslinking

With the proven track record of epi-off corneal crosslinking (CXL) in halting keratoconus (KCN) progression and the forthcoming availability of epi-on CXL, let’s discuss the specific steps optometrists should take in comanaging these patients.

Optometric Management

April 30, 2025

FDA Approves FcRn Blocker for Broad gMG Use

The first FcRn blocker for both adult and pediatric generalized myasthenia gravis has been approved by the FDA, based on data showing sustained symptom improvement and IgG reduction in clinical trials.

Conexiant